CONMED Corporation
CNMD
$58.29
-$0.6278-1.07%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 345.94M | 316.70M | 332.10M | 312.27M | 327.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 345.94M | 316.70M | 332.10M | 312.27M | 327.05M |
| Cost of Revenue | 147.60M | 137.71M | 148.37M | 138.71M | 142.77M |
| Gross Profit | 198.34M | 179.00M | 183.73M | 173.57M | 184.28M |
| SG&A Expenses | 131.42M | 126.73M | 131.22M | 129.90M | 128.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 292.19M | 277.99M | 293.69M | 282.21M | 284.88M |
| Operating Income | 53.75M | 38.71M | 38.41M | 30.07M | 42.17M |
| Income Before Tax | 43.64M | 56.46M | 37.51M | 25.42M | 40.68M |
| Income Tax Expenses | 9.89M | 7.47M | 7.54M | 5.71M | 7.61M |
| Earnings from Continuing Operations | 33.76M | 48.98M | 29.98M | 19.71M | 33.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.76M | 48.98M | 29.98M | 19.71M | 33.07M |
| EBIT | 53.75M | 38.71M | 38.41M | 30.07M | 42.17M |
| EBITDA | 70.36M | 56.68M | 56.25M | 48.11M | 58.47M |
| EPS Basic | 1.09 | 1.59 | 0.97 | 0.64 | 1.08 |
| Normalized Basic EPS | 0.91 | 0.60 | 0.58 | 0.42 | 0.66 |
| EPS Diluted | 1.08 | 1.57 | 0.96 | 0.63 | 1.05 |
| Normalized Diluted EPS | 0.90 | 0.59 | 0.58 | 0.41 | 0.65 |
| Average Basic Shares Outstanding | 30.92M | 30.86M | 30.81M | 30.78M | 30.76M |
| Average Diluted Shares Outstanding | 31.15M | 31.11M | 31.11M | 31.27M | 31.50M |
| Dividend Per Share | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Payout Ratio | 18.30% | 12.58% | 20.54% | 31.22% | 18.59% |
